These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37230955)

  • 1. Plasma arginine metabolites in health and chronic kidney disease.
    Au AYM; Mantik K; Bahadory F; Stathakis P; Guiney H; Erlich J; Walker R; Poulton R; Horvath AR; Endre ZH
    Nephrol Dial Transplant; 2023 Nov; 38(12):2767-2775. PubMed ID: 37230955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
    J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Sapa H; Gutiérrez OM; Shlipak MG; Katz R; Ix JH; Sarnak MJ; Cushman M; Rhee EP; Kimmel PL; Vasan RS; Schrauben SJ; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
    Am J Kidney Dis; 2022 Oct; 80(4):502-512.e1. PubMed ID: 35351578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
    Krzystek-Korpacka M; Wiśniewski J; Fleszar MG; Bednarz-Misa I; Bronowicka-Szydełko A; Gacka M; Masłowski L; Kędzior K; Witkiewicz W; Gamian A
    Oxid Med Cell Longev; 2019; 2019():5965721. PubMed ID: 31396302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohort.
    Maas R; Mieth M; Titze SI; Hübner S; Fromm MF; Kielstein JT; Schmid M; Köttgen A; Kronenberg F; Krane V; Hausknecht B; Eckardt KU; Schneider MP
    Nephrol Dial Transplant; 2020 Jul; 35(7):1187-1195. PubMed ID: 30476224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
    Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
    Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Schrauben SJ; Sapa H; Xie D; Zhang X; Anderson AH; Shlipak MG; Hsu CY; Shafi T; Mehta R; Bhat Z; Brown J; Charleston J; Chen J; He J; Ix JH; Rao P; Townsend R; Kimmel PL; Vasan RS; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
    Nephrol Dial Transplant; 2023 Nov; 38(12):2809-2815. PubMed ID: 37230949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
    Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
    PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry.
    Wang S; Vicente FB; Miller A; Brooks ER; Price HE; Smith FA
    Clin Chem Lab Med; 2007; 45(10):1305-12. PubMed ID: 17663630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of the L-Arginine/Dimethylarginine/Nitric Oxide Pathway in People with Chronic Airflow Obstruction and Obstructive Sleep Apnoea.
    Hannemann J; Thorarinnsdottir EH; Amaral AFS; Schwedhelm E; Schmidt-Hutten L; Stang H; Benediktsdottir B; Gunnarsdóttir I; Gislason T; Böger R
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
    Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
    Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
    Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
    Szlęzak D; Ufnal M; Drapała A; Samborowska E; Wróbel M
    Amino Acids; 2023 Apr; 55(4):529-539. PubMed ID: 36802034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
    Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.
    Jaźwińska-Kozuba A; Martens-Lobenhoffer J; Surdacki A; Kruszelnicka O; Rycaj J; Godula-Stuglik U; Bode-Böger SM
    Int J Mol Sci; 2012 Nov; 13(11):15464-74. PubMed ID: 23203136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.